Brian Hess to Lymphoma, Non-Hodgkin
This is a "connection" page, showing publications Brian Hess has written about Lymphoma, Non-Hodgkin.
Connection Strength
0.183
-
Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma. Clin Cancer Res. 2021 06 15; 27(12):3339-3350.
Score: 0.183